Mitsubishi UFJ Trust & Banking’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-240,720
| Closed | -$1.81M | – | 1115 |
|
|
2024
Q2 | $1.81M | Sell |
240,720
-29,640
| -11% | -$222K | ﹤0.01% | 801 |
|
|
2024
Q1 | $2.7M | Sell |
270,360
-31,130
| -10% | -$310K | 0.01% | 755 |
|
|
2023
Q4 | $2.97M | Sell |
301,490
-47,980
| -14% | -$473K | 0.01% | 738 |
|
|
2023
Q3 | $2.67M | Sell |
349,470
-9,060
| -3% | -$69.3K | 0.01% | 752 |
|
|
2023
Q2 | $2.68M | Sell |
358,530
-8,860
| -2% | -$66.2K | 0.01% | 758 |
|
|
2023
Q1 | $2.45M | Hold |
367,390
| – | – | 0.01% | 753 |
|
|
2022
Q4 | $2.83M | Hold |
367,390
| – | – | 0.01% | 742 |
|
|
2022
Q3 | $3.91M | Sell |
367,390
-6,000
| -2% | -$63.8K | 0.01% | 700 |
|
|
2022
Q2 | $3.04M | Hold |
373,390
| – | – | 0.01% | 743 |
|
|
2022
Q1 | $2.67M | Hold |
373,390
| – | – | 0.01% | 773 |
|
|
2021
Q4 | $6.4M | Sell |
373,390
-25,030
| -6% | -$429K | 0.01% | 697 |
|
|
2021
Q3 | $9.17M | Buy |
+398,420
| New | +$9.17M | 0.02% | 626 |
|